Interaction with PI3-kinase contributes to the cytotoxic activity of apoptin
S Maddika1, E Wiechec, S R Ande
1Manitoba Institute of Cell Biology, CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.
Abstract:
Apoptin, a small protein from the chicken anemia virus, has attracted attention because of its specificity in killing tumor cells. Localization of apoptin in the nucleus of tumor cells has been shown to be vital for proapoptotic activity, however, targeted expression of apoptin in the nucleus of normal cells does not harm the cells, indicating that nuclear localization of apoptin is insufficient for its cytotoxicity. Here, we demonstrate for the first time that apoptin interacts with the SH3 domain of p85, the regulatory subunit of phosphoinositide 3-kinase (PI3-K), through its proline-rich region. Apoptin derivatives devoid of this proline-rich region do not interact with p85, are unable to activate PI3-K, and show impaired apoptosis induction. Moreover, apoptin mutants containing the proline-rich domain are sufficient to elevate PI3-K activity and to induce apoptosis in cancer cells. Downregulation of p85 leads to nuclear exclusion of apoptin and impairs cell death induction, indicating that interaction with the p85 PI3-K subunit essentially contributes to the cytotoxic activity of apoptin.
Insights
Apoptin, a viral protein, specifically targets tumor cells. Its interaction with the p85 subunit of phosphoinositide 3-kinase (PI3-K) is crucial for activating cell death pathways in cancer.
Area of Science:
- Molecular Biology
- Oncology
- Virology
Background:
- Apoptin, a protein from chicken anemia virus, selectively induces apoptosis in tumor cells.
- Nuclear localization of apoptin is necessary but not sufficient for its tumor-specific cytotoxicity.
- The precise mechanism underlying apoptin's tumor-killing ability remains incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanism by which apoptin induces tumor cell death.
- To investigate the interaction between apoptin and cellular proteins involved in cell survival pathways.
- To determine the role of phosphoinositide 3-kinase (PI3-K) signaling in apoptin-mediated apoptosis.
Main Methods:
- Protein-protein interaction assays to identify apoptin binding partners.
- Site-directed mutagenesis to map the apoptin interaction domain.
- Analysis of PI3-K activity in cells expressing apoptin and its mutants.
- Assessment of apoptosis induction and cell death in cancer cells and normal cells.
- RNA interference to downregulate p85 expression and evaluate its effect on apoptin activity.
Main Results:
- Apoptin directly interacts with the SH3 domain of p85, the regulatory subunit of PI3-K, via its proline-rich region.
- Apoptin mutants lacking the proline-rich region fail to interact with p85, activate PI3-K, or induce apoptosis.
- Expression of apoptin mutants containing the proline-rich domain restores PI3-K activity and triggers apoptosis in cancer cells.
- Downregulation of p85 prevents nuclear localization of apoptin and abrogates its cell death-inducing capacity.
Conclusions:
- The interaction between apoptin and the p85 subunit of PI3-K is essential for apoptin's cytotoxic activity against tumor cells.
- Apoptin activates PI3-K signaling, leading to apoptosis, and this activation is dependent on its proline-rich region and interaction with p85.
- Targeting the apoptin-p85 interaction represents a potential therapeutic strategy for cancer treatment.
More Related Videos
Related Concept Videos
The Extrinsic Apoptotic Pathway
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


